5 results
SC TO-T
EX-99
DBTX
Decibel Therapeutics, Inc.
25 Aug 23
Third party tender offer statement
7:46am
2,097,314 Shares (representing approximately 8.3% of the outstanding Shares as of such date).
Christine A. Poon, who is the Lead Independent Director
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
and Chief Scientific Officer, respectively. The Board also plans to appoint current director Christine A. Poon as the Lead Independent Director of the Board
8-K
REGN
Regeneron Pharmaceuticals, Inc.
17 Apr 23
Departure of Directors or Certain Officers
7:37am
and Chief Executive Officer and President and Chief Scientific Officer, respectively) and to designate Christine A. Poon as the Lead Independent Director
- Prev
- 1
- Next